Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 14 of 48 for:    Venetoclax AND Bcl-

CRC043: A Phase II Study of Venetoclax in Combination With Dose-adjusted EPOCH-R for Patients With Richter's Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03054896
Recruitment Status : Active, not recruiting
First Posted : February 16, 2017
Last Update Posted : November 14, 2019
Sponsor:
Collaborator:
Genentech, Inc.
Information provided by (Responsible Party):
Matthew S. Davids, MD, Dana-Farber Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : September 1, 2020
Estimated Study Completion Date : September 1, 2023